Lumykras Euroopa Liit - taani - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - carcinom, ikke-småcellet lunge - antineoplastiske midler - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Celmantin 10 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

celmantin 10 mg filmovertrukne tabletter

medochemie ltd. - rosuvastatin calcium - filmovertrukne tabletter - 10 mg

Celmantin 20 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

celmantin 20 mg filmovertrukne tabletter

medochemie ltd. - rosuvastatin calcium - filmovertrukne tabletter - 20 mg

Celmantin 40 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

celmantin 40 mg filmovertrukne tabletter

medochemie ltd. - rosuvastatin calcium - filmovertrukne tabletter - 40 mg

Crestor 10 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

crestor 10 mg filmovertrukne tabletter

grünenthal gmbh - rosuvastatin calcium - filmovertrukne tabletter - 10 mg